Angiotensin II induces expression of the Tie2 receptor ligand, angiopoietin-2, in bovine retinal endothelial cells

Diabetes

Volumn 50, Issue 4, 2001, Pages 867-875

  Otani, Atsushi ^a   Takagi, Hitoshi ^a   Oh, Hideyasu ^a   Koyama, Shinji ^a   Honda, Yoshihito ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN;

ANIMAL CELL; ARTICLE; CATTLE; DIABETES MELLITUS; DIABETIC RETINOPATHY; LIGAND BINDING; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0035088071     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.50.4.867     Document Type: Article

References (53)

1. Mechanisms of angiogenesis
2. Signaling vascular morphogenesis and maintenance
3. High affinity VEGF binding and developmental expression suggest Flk-1 as a major regulator of vasculogenesis and angiogenesis
4. A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases
5. The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor
6. Tie-1 and Tie-2 define another class of putative receptor tyrosine kinase genes expressed in early embryonic vascular system
7. The receptor tyrosine kinase TIE is required for integrity and survival of vascular endothelial cells
8. Distinct roles of the receptor tyrosine kinases Tie-1 and Tie-2 in blood vessel formation
9. Dominant-negative and targeted null mutations in the endothelial receptor tyrosine kinase, tek, reveal a critical role in vasculogenesis of the embryo
10. Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice
11. Vascular dysmorphogenesis caused by an activating mutation in the receptor tyrosine kinase TIE2
12. Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis
13. Isolation of angiopoietin-1, a ligand for the TIE2 receptor, by secretion-trap expression cloning
14. VEGF and VEGF-C: Specific induction of angiogenesis and lymphangiogenesis in the differentiated avian chorioallantoic membrane
15. Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis
16. Tie2 expression and phosphorylation in angiogenic and quiescent adult tissues
17. Tie2 receptor ligands, angiopoietin-1 and angiopoietin-2, modulate VEGF-induced postnatal neovascularization
18. Molecular biology of angiotensin II biosynthesis and receptors
19. Induction of platelet-derived growth factor A-chain and c-myc gene expressions by angiotensin II in cultured rat vascular smooth muscle cells
20. Angiotensin II regulates insulin-like growth factor I gene expression in vascular smooth muscle cells
21. Early induction of transforming growth factor-beta via angiotensin II type 1 receptors contributes to cardiac fibrosis in induced by long-term blockade of nitric oxide synthesis in rats
22. Inhibitors of angiotensin-converting enzyme prevent myointimal proliferation after vascular injury
23. Molecular basis of human hypertension: Role of angiotensinogen
24. Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction
25. Effect of lisinopril on progression of retinopathy in normotensive people with type 1 diabetes: The EUCLID Study Group
26. The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy: The Collaborative Study Group
27. Angiotensin II potentiates vascular endothelial growth factor-induced angiogenic activity in retinal nucrocapillary endothelial cells
28. Angiotensin II stimulates vascular endothelial growth factor (VEGF) expression in bovine retinal microcapillary pericytes
29. Receptors and growth-promoting effects of insulin and insulin-like growth factors on cells from bovine retinal capillaries and aorta
30. Differential display of eukaryotic messenger RNA by means of the polymerase chain reaction
31. Vascular endothelial growth factor (VEGF) and hypoxia regulate angiopoietin2 expression in retinal vascular endothelial cells
32. Neovascularization produced by angiotensin II
33. Angiopoietin-1 induces sprouting angiogenesis in vitro
34. Chemotactic properties of angiopoietin-1 and -2, ligands for the endothelial-specific receptor tyrosine kinase Tie2
35. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis
36. Increased vascular endothelial growth factor levels in the vitreous of eyes with proliferative diabetic retinopathy
37. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders
38. Biologic significance of angiopoietin-2 expression in human hepatocellular carcinoma
39. Cell type-specific expression of angiopoietin-1 and angiopoietin-2 suggests a role in glioblastoma angiogenesis
40. Regulation of angiopoietin-2 mRNA levels in bovine microvascular endothelial cells by cytokines and hypoxia
41. Angiotensin levels in the eye
42. An ocular renin-angiotensin system: Immunohistochemistry of angiotensinogen
43. Demonstration of renin mRNA, angiotensinogen mRNA, and angiotensin converting enzyme mRNA expression in the human eye: Evidence for an intraocular renin-angiotensin system
44. Angiotensin II in the rabbit retina
45. Timmermans PBMWM: Identification of angiotensin II receptor subtypes
46. Preliminary biochemical characterization of two angiotensin II receptor subtypes
47. Pathophysiological role of angiotensin II type 2 receptor in cardiovascular and renal diseases
48. Expression of the AT2 receptor developmentally programs extracellular signal-regulated kinase activity and influences fetal vascular growth
49. Angiotensin blockade inhibits activation of mitogen-activated protein kinases in rat balloon-injured artery
50. Angiotensin II stimulates ERK via two pathways in epithelial cells: Protein kinase C suppresses a G-protein coupled receptor-EGF receptor transactivation pathway
51. 2+/calmodulin-dependent transactivation of epidermal growth factor receptor
52. How MAP kinases are regulated
53. Angiotensin II activates mitogen-activated protein kinase via protein kinase C and Ras/Raf-1 kinase in bovine adrenal glomerulosa cells